Top 10 Best Trial Design Software of 2026

GITNUXSOFTWARE ADVICE

Science Research

Top 10 Best Trial Design Software of 2026

Top 10 trial design software ranked for clinical teams, with comparisons of Medidata Rave, Oracle Clinical One, Veeva Vault, and others.

31 min readUpdated Editorially scoped research
How we ranked these tools
01Editorial Scope

An editor sets the topic, the inclusion criteria, and the evaluation framework before research starts.

02Source Research

AI search agents find sources, extract figures with provenance, and aggregate written reviews. They also transcribe video reviews and podcasts.

Read our full methodology →

Framework: Features 40% · Ease 30% · Value 30%

Gitnux may earn a commission through links on this page — this does not influence rankings. Editorial policy

Trial design software supports study planning by computing sample sizes, simulating endpoints, and generating protocols that downstream systems can implement. This ranked list targets clinical analytics leads, biostatistics teams, and operations managers who must compare modeling rigor and deployment fit, not marketing claims, across both statistical and clinical workflow tools.

IBM SPSS SamplePower is the best fit when clinical statisticians need repeatable power and sample-size planning from standard assumptions, whereas Berry Consultants FACTS works best for simulation-driven Bayesian iteration that keeps assumptions documented, and if you need a low-cost frequentist feasibility calculator, G*Power is the simplest entry.

Editor’s top 3 picks

Three quick recommendations before you dive into the full comparison below — each one leads on a different dimension.

Editor pick
1

IBM SPSS SamplePower

Input-driven power and sample size computation with scenario recalculation suited to rapid feasibility iterations.

Best for: Fits when clinical statisticians need repeatable power and sample size planning from standardized assumptions.

2

Berry Consultants FACTS

Editor pick

Assumption-to-output traceability across trial simulations, including the ability to retain design inputs used for planning decisions.

Best for: Fits when clinical planning teams need repeatable simulation-driven design iteration with documented assumptions.

3

Cytel EAST

Editor pick

Design-to-simulation traceability keeps interim decision rules consistent across re-simulations and protocol artifact updates.

Best for: Fits when teams must iterate adaptive design decisions using repeatable simulation assumptions and protocol outputs.

Comparison Table

1
enterprise
9.0/10
Overall
2
vertical specialist
8.7/10
Overall
3
enterprise
8.4/10
Overall
4
enterprise
8.1/10
Overall
5
7.8/10
Overall
6
7.5/10
Overall
7
7.2/10
Overall
8
6.9/10
Overall
9
6.6/10
Overall
10
vertical specialist
6.4/10
Overall
#1

IBM SPSS SamplePower

enterprise

Statistical power and sample size software used to plan clinical and experimental studies.

9.0/10
Overall
Features9.3/10
Ease of Use9.0/10
Value8.7/10
Standout feature

Input-driven power and sample size computation with scenario recalculation suited to rapid feasibility iterations.

SPSS SamplePower focuses on translating design assumptions into power or sample size outputs for pre-specified models, including common test families and parameter settings. The workflow emphasizes structured inputs for key drivers like effect sizes, variances, allocation, and significance levels, and it produces design-ready numeric results with consistent recalculation. This makes it a practical choice for teams that already standardize on a statistical plan and need a tool for rapid re-estimation across scenarios.

A tradeoff is that it does not replace study execution planning and data capture tools, so it typically does not produce end-to-end outputs for a complete trial submission package. SPSS SamplePower fits best when clinical analysts must run iterative feasibility checks for a protocol draft, or when interim planning requires quick recalculation under updated assumptions.

Pros
  • +Structured power and sample size inputs support fast scenario recalculation
  • +Simulation-oriented planning fits feasibility checks beyond single-point calculations
  • +Outputs stay parameter-driven and easy to trace back to assumptions
  • +Statistical coverage matches common trial testing and design planning tasks
Cons
  • –Limited integration with clinical operations systems reduces end-to-end automation
  • –Automation and API access are not the primary workflow compared with enterprise design suites
  • –Adaptive trial mechanics require careful manual scenario setup
  • –Protocol-level deliverables and document assembly are outside core scope
Use scenarios
  • Clinical biostatisticians

    Power re-estimation for protocol amendments

    Faster amendment-ready design numbers

  • Clinical trial leads

    Feasibility planning across scenarios

    Clear go-no-go feasibility evidence

Show 1 more scenario
  • Academic and sponsor analysts

    Simulation-based planning checks

    More defensible planning assumptions

    Use simulation-oriented settings to sanity check assumptions beyond single analytic formulas.

Best for: Fits when clinical statisticians need repeatable power and sample size planning from standardized assumptions.

#2

Berry Consultants FACTS

vertical specialist

Bayesian adaptive trial design software for simulation, operating characteristics, and protocol planning.

8.7/10
Overall
Features8.8/10
Ease of Use8.5/10
Value8.8/10
Standout feature

Assumption-to-output traceability across trial simulations, including the ability to retain design inputs used for planning decisions.

Berry Consultants FACTS is a trial design tool used by clinical planning teams to translate study constraints into workable design outputs with an audit-ready trail of inputs. The tool’s trial simulation modeling workflow is geared toward comparing design variants under explicit assumptions instead of only presenting static calculations. FACTS also supports master schedule generation inputs that help teams reason about feasibility alongside design decisions.

A key tradeoff is that design outcomes stay tied to the scenarios the tool can simulate and schedule, so teams may need spreadsheet or external modeling for niche adaptations or uncommon endpoints. FACTS fits best when a clinical group needs repeatable trial planning cycles with documented assumptions and faster iteration across design options.

Pros
  • +Trial simulation modeling workflow supports side-by-side design assumption comparisons
  • +Documented input trail helps align design assumptions across planning stakeholders
  • +Master schedule generation inputs connect design parameters to feasibility planning
  • +Governance-focused planning supports structured review of trial design choices
Cons
  • –Simulation coverage depends on modeled assumptions and may not fit every niche design
  • –Outputs require downstream formatting for specific eTMF or sponsor template needs
Use scenarios
  • Clinical operations planning teams

    Stress test feasibility against enrollment assumptions

    Fewer late design changes

  • Biostatistics and study design teams

    Iterate design options using repeatable inputs

    Faster design iteration cycles

Show 1 more scenario
  • Program management groups

    Connect design parameters to timelines

    Earlier risk identification

    Teams use master schedule generation inputs to align design choices with execution timing expectations.

Best for: Fits when clinical planning teams need repeatable simulation-driven design iteration with documented assumptions.

#3

Cytel EAST

enterprise

Adaptive and fixed trial design software for sample size, group sequential design, and simulation.

8.4/10
Overall
Features8.3/10
Ease of Use8.7/10
Value8.3/10
Standout feature

Design-to-simulation traceability keeps interim decision rules consistent across re-simulations and protocol artifact updates.

Cytel EAST is built around a model-first workflow where trial parameters, adaptive decision rules, and simulation settings are defined in a structured way. Bayesian dose-finding configuration and DLT dose-escalation logic can be tested across scenarios to compare design behavior under different assumptions. The output emphasis stays on trial-level artifacts and decision traceability, rather than only producing a report. This makes EAST a strong match for clinical teams that expect frequent design iterations and want consistent linkage between assumptions, simulations, and the protocol narrative.

A tradeoff is that EAST’s deepest value comes when teams adopt its structured workflow early and keep design changes within the tool, since exporting assumptions to other authoring systems can fragment traceability. A common usage situation is a dose-escalation study where interim rules need to be tuned and re-simulated multiple times before protocol submission. Teams that prefer flexible spreadsheet-first iteration without a formal modeling step often find the workflow heavier than their current practice.

Pros
  • +Structured adaptive decision logic linked to simulation iterations
  • +Bayesian dose-finding and DLT escalation rules support scenario testing
  • +Protocol artifact generation stays consistent with design assumptions
  • +Design traceability reduces rework across repeated design cycles
Cons
  • –Best results require teams to follow the tool’s modeling workflow
  • –Some downstream authoring needs still require manual translation of outputs
  • –RBAC and audit-log depth can depend on how deployments are administered
Use scenarios
  • Biostatistics teams

    Tune Bayesian dose-finding interim rules

    Fewer late-stage design revisions

  • Clinical development leads

    Align protocol narrative to adaptive logic

    Reduced assumption drift

Show 1 more scenario
  • Program modeling groups

    Re-run simulations after design parameter changes

    Faster iteration cycles

    Update design inputs and re-simulate to compare how trial behavior shifts.

Best for: Fits when teams must iterate adaptive design decisions using repeatable simulation assumptions and protocol outputs.

#4

nQuery

enterprise

Sample size and clinical trial design software for superiority, non-inferiority, equivalence, and adaptive studies.

8.1/10
Overall
Features8.2/10
Ease of Use8.0/10
Value8.2/10
Standout feature

Protocol simulation that ties interim analysis and adaptive decision rules to measurable operating characteristics.

nQuery from Statsols is a trial design tool focused on planning, simulations, and interim decision workflows for studies with complex statistical requirements. It supports sample size planning, power calculations, and protocol simulation so teams can evaluate operating characteristics before lock.

Its adaptive and Bayesian-ready workstreams center on defining decision rules and then testing them under simulated enrollment and response patterns. For trial teams that need repeatable planning outputs, nQuery provides structured project artifacts that tie design assumptions to simulated trial outcomes.

Pros
  • +Protocol simulation keeps interim rules and enrollment assumptions testable
  • +Structured design inputs reduce ambiguity between planning and analysis drafts
  • +Adaptive and Bayesian planning workflows support decision rule specification
  • +Exports support review-ready handoffs between biostats and clinical operations
Cons
  • –Specialized statistical modeling depth can increase setup time for basic studies
  • –Integration surface for CDISC and eTMF data flows is not the main design focus
  • –Long-running simulation projects can strain performance on limited compute
  • –Governance features like RBAC and audit logging are not a primary strength

Best for: Fits when clinical biostatistics teams need interim-ready planning with heavy simulation and decision-rule traceability.

#5

Sealed Envelope

SMB

Online tools for randomization schedule generation, sample size calculation, and minimization in clinical trials.

7.8/10
Overall
Features7.6/10
Ease of Use8.0/10
Value8.0/10
Standout feature

Configurable form and metadata templates for governed eTMF document publishing tied to study document lifecycle steps.

Sealed Envelope provides eTMF-focused trial document design and publishing workflows built around templated forms and configurable metadata. The solution supports protocol-driven document generation that reduces manual copy edits across versions.

Sealed Envelope also supports automation hooks for review circulation and controlled publishing steps to keep study artifacts consistent across teams. Its trial design support centers on structured content reuse rather than building statistical engines or adaptive design logic.

Pros
  • +Template-driven document creation reduces repetitive protocol-to-form work
  • +Publishing workflows support controlled review steps and version discipline
  • +Structured metadata supports consistent document labeling and downstream reuse
  • +Automation hooks reduce manual coordination between review stakeholders
Cons
  • –Not designed for protocol simulation or adaptive randomization calculations
  • –Limited coverage for statistical plan generation compared with analytics-first tools
  • –Complex multi-template setups need careful configuration discipline
  • –API and integration depth may be narrower than CRO-grade eClinical suites

Best for: Fits when clinical teams need governed eTMF document design and publishing workflows with template reuse across protocol amendments.

#6

G*Power

SMB

Free statistical power analysis tool for computing sample sizes across F-tests, t-tests, and chi-square tests.

7.5/10
Overall
Features7.7/10
Ease of Use7.4/10
Value7.4/10
Standout feature

Fast frequentist power and sample size calculation across common parametric test setups with minimal setup friction.

G*Power is a statistical power and sample-size trial design tool that focuses on frequentist calculations rather than end-to-end protocol workflows. It supports common study settings like t tests, ANOVA, linear models, correlation tests, and survival-style analyses in a calculator-driven interface.

The core capability is fast exploration of effects, alpha, power, and allocation assumptions without requiring trial simulation modeling or adaptive design scripting. For teams that mainly need defensible sample size calculations to inform feasibility and interim planning, G*Power can reduce iteration time compared with building custom spreadsheets.

Pros
  • +Calculator-first workflow for rapid alpha and power sensitivity checks
  • +Covers frequentist test families like t tests, ANOVA, and linear models
  • +Quick parameter changes support multiple feasibility scenarios
  • +Runs locally in a way that avoids dependency on a governed cloud pipeline
Cons
  • –No native support for Bayesian adaptive designs or Bayesian dose-finding
  • –Limited coverage for protocol artifacts like schedules, randomization plans, and interim decision logic
  • –No CDISC SDTM mapping or eTMF integration workflow for trial deliverables
  • –Does not provide API access or automation hooks for batch sample-size runs

Best for: Fits when teams need frequentist sample size calculations for feasibility drafts and internal review cycles.

#7

Veeva Vault Clinical

enterprise

Unified clinical operations suite covering study design, eTMF, CTMS, and site startup.

7.2/10
Overall
Features7.2/10
Ease of Use7.1/10
Value7.4/10
Standout feature

Vault workflow and governance for protocol-relevant artifacts stay synchronized with Vault-based study operations.

Veeva Vault Clinical centers trial design workflow artifacts and governance inside the Vault environment, which reduces drift between protocol authoring and downstream operational handling. Study-specific configuration and structured review steps support change tracking that regulators commonly expect for protocol documents and their associated study governance trail.

Integration depth is strongest when design outputs need alignment with Veeva’s broader clinical record lifecycle, because permissions, audit visibility, and study context carry through the same Vault study. Automation can be achieved through Veeva’s API surface for workflow-adjacent operations such as provisioning, metadata handling, and triggering study process steps.

Trial modeling breadth is more limited for advanced design work such as complex adaptive dose-finding engines, interim analysis planning, or full protocol simulation workflows that act as a statistical planning hub. For those cases, Vault Clinical works better as a governed workflow layer that coordinates artifacts and review rather than as the sole design and inference engine.

Pros
  • +Vault-native study configuration keeps protocol artifacts consistent across operations
  • +Built-in review and change tracking supports structured protocol governance
  • +Role-based access control and audit log fit regulated workflow expectations
  • +Extensibility through published APIs supports automation of design-adjacent tasks
Cons
  • –Protocol simulation and adaptive design engines require external tooling, not native orchestration
  • –Workflow configuration can require governance discipline to avoid inconsistent study setup
  • –Trial design modeling coverage is thinner than systems focused on statistical design planning
  • –Deep operational integration increases dependency on Vault-adjacent capabilities

Best for: Fits when protocol teams need governed Vault workflows that hand off cleanly to clinical operations.

#8

Oracle Clinical One

enterprise

Cloud clinical trial management system supporting study design, randomization, and supply management.

6.9/10
Overall
Features6.9/10
Ease of Use6.8/10
Value7.1/10
Standout feature

End-to-end traceability from study configuration to CDISC-aligned downstream artifacts via controlled provisioning and audit logging.

Oracle Clinical One is an Oracle-focused trial design and clinical operations environment that emphasizes governance, lineage, and standards alignment for study setup. It supports protocol workflow configuration and trial build tasks that connect study definitions to downstream clinical processes, including data mapping expectations.

Its automation surface is strongest around study provisioning, configuration control, and controlled handoffs into CDISC-aligned representations used later in the life cycle. Oracle Clinical One is most practical when governance and integration depth matter as much as design-time authoring for clinical teams.

Pros
  • +Study provisioning flows keep protocol configuration and downstream processes aligned
  • +Governance controls support RBAC patterns for controlled authoring and review
  • +Extensibility points fit enterprise integration with other Oracle clinical systems
  • +Audit log trails support traceability across protocol build and configuration changes
Cons
  • –Adaptive design configuration needs specialized configuration work for complex randomization
  • –Protocol simulation coverage is limited compared with tools centered on modeling workflows

Best for: Fits when enterprise teams require strict study configuration governance and deep integration into Oracle clinical workflows.

#9

Castor EDC

SMB

Cloud-based electronic data capture and study builder for academic and commercial clinical trials.

6.6/10
Overall
Features6.9/10
Ease of Use6.4/10
Value6.5/10
Standout feature

Centralized study configuration that ties visit schedules, CRF routing, and validation into one editable workflow definition.

Castor EDC generates clinical trial data collection workflows from structured study definitions, with configuration centered on forms, edit checks, and study calendars. The product supports protocol-driven setup for visits, CRF routing, and data validation, which helps teams standardize operational feasibility artifacts alongside case report buildout.

Castor EDC also targets interoperability for downstream analysis by supporting common clinical data exchange patterns such as CDISC-aligned mappings and exportable study data sets. Across study builds, the system emphasizes controlled configuration so protocol changes can be reflected in instrument logic without rebuilding the entire workflow.

Pros
  • +Protocol-to-CRF configuration reduces manual duplication across visits and forms
  • +Edit checks and validation logic are built into the study data capture flow
  • +Data exports support downstream analysis and integration needs
  • +Study configuration stays centralized instead of split across multiple tools
Cons
  • –Adaptive design artifacts like interim analysis planning are not a native design module
  • –Integration coverage for deep EDC-analytics pipelines depends on external tooling
  • –Complex multi-entity randomization structures require careful workflow modeling
  • –Change control for heavy protocol revisions needs disciplined configuration management

Best for: Fits when clinical teams need configurable EDC buildout and structured validation for protocol-driven studies.

#10

OpenClinica

vertical specialist

Open source clinical trial management and electronic data capture platform for regulated studies.

6.4/10
Overall
Features6.3/10
Ease of Use6.2/10
Value6.6/10
Standout feature

Query and data issue resolution workflows with audit tracking across study operations.

OpenClinica focuses on clinical trial data capture and study management with an audit-ready workflow built for regulated operations. Core capabilities include configurable study setup, electronic data capture workflows, query handling, and role-based access controls.

It also supports integration patterns for importing and exporting study data and for connecting related systems used in trial operations and reporting. For trial teams that need governance around forms, changes, and data flow, OpenClinica offers a controllable operational backbone.

Pros
  • +Audit-oriented workflows for form changes, queries, and approvals
  • +Configurable study setup supports repeatable operational patterns
  • +Query management tracks data issues through resolution
  • +Role-based access controls support separation of duties
Cons
  • –Deep setup and configuration work increases admin effort
  • –Adaptive design execution is not a native focus for trial randomization logic
  • –Reporting and analytics require additional configuration for advanced outputs
  • –Integration paths depend on available connectors and implementation effort

Best for: Fits when trial operations teams need governed EDC workflows and disciplined data quality handling.

Conclusion

After evaluating 10 trial design software, IBM SPSS SamplePower stands out as our overall top pick — it scored highest across our combined criteria of features, ease of use, and value, which is why it sits at #1 in the rankings above.

Our Top Pick
IBM SPSS SamplePower

Use the comparison table and detailed reviews above to validate the fit against your own requirements before committing to a tool.

How to Choose the Right Trial Design Software

This guide focuses on trial design software used by clinical planning teams to iterate protocol-facing statistical decisions with traceable inputs and repeatable outputs. The coverage includes IBM SPSS SamplePower, Berry Consultants FACTS, Cytel EAST, nQuery, Sealed Envelope, G*Power, Veeva Vault Clinical, Oracle Clinical One, Castor EDC, and OpenClinica.

The short list targets teams managing simulation-driven interim decision rules, governed protocol artifact configuration, and operations handoffs. It also addresses where tools stop at planning and where they connect into downstream clinical workflows through configuration and governance features.

Trial Design Software for protocol simulation, interim decision rules, and governed trial configuration

Trial design software generates and validates statistical operating characteristics from structured design inputs, then keeps those decisions consistent across iterations. IBM SPSS SamplePower leads with input-driven power and sample size computation that supports scenario recalculation for rapid feasibility iterations.

Berry Consultants FACTS centers on assumption-to-output traceability across trial simulations, including retention of the design inputs used for planning decisions. Some tools in this category focus on governed study setup and artifact synchronization, like Veeva Vault Clinical and Oracle Clinical One, while others provide operations-oriented workflows that do not include a native adaptive design or simulation engine, like Castor EDC and OpenClinica.

What to verify in Trial Design Software before standardizing protocols

Trial design software must turn structured design inputs into measurable operating characteristics while keeping the interim decision rules traceable when assumptions change. This category also varies sharply in where governance lives. Some tools focus on modeling and simulation traceability, while others focus on protocol artifact configuration and controlled review inside enterprise systems.

  • Input-to-output scenario recalculation with decision-rule traceability

    IBM SPSS SamplePower supports input-driven power and sample size computation with scenario recalculation for rapid feasibility iterations. Cytel EAST ties adaptive decision logic to simulation iterations so interim rules remain consistent when protocol artifacts are updated.

  • Assumption lineage retained across design iterations

    Berry Consultants FACTS keeps an assumption-to-output trail so stakeholders can retain the design inputs used for planning decisions. nQuery connects protocol simulation outputs to interim analysis and adaptive decision rules with measurable operating characteristics.

  • Interim and adaptive coverage aligned to modeling workflows

    Cytel EAST provides Bayesian dose-finding and DLT escalation rule scenario testing for adaptive designs. nQuery provides protocol simulation tied to interim-ready planning, which supports adaptive decision-rule traceability even when downstream CDISC flows need separate authoring.

  • Governed protocol artifact configuration and controlled change tracking

    Oracle Clinical One offers end-to-end traceability from study configuration to CDISC-aligned downstream artifacts through controlled provisioning and audit logging. Veeva Vault Clinical keeps Vault-based protocol artifacts synchronized with built-in review and change tracking for structured protocol governance.

  • Template-driven eTMF publishing workflows tied to document lifecycle steps

    Sealed Envelope uses configurable form and metadata templates for governed eTMF document publishing tied to study document lifecycle steps. It reduces repetitive protocol-to-form work, but it does not provide a native protocol simulation or adaptive design calculation engine.

  • Operational study configuration and validation workflows that stop short of adaptive engines

    Castor EDC centralizes study configuration to tie visit schedules, CRF routing, and validation into one editable workflow definition. OpenClinica emphasizes audit-oriented workflows for form changes, queries, and approvals, while adaptive design execution for randomization logic is not a native focus.

Decision framework for selecting the right Trial Design Software surface

The selection starts by deciding whether the primary workflow is modeling-first simulation iteration or governed protocol artifact setup in enterprise systems. The correct choice also depends on how the organization wants interim decision rules to survive re-simulations, versioning, and downstream handoffs.

  • Choose simulation-first tooling when interim decision rules must be re-simulated from structured inputs

    Select IBM SPSS SamplePower when clinical statisticians need standardized assumptions turned into power and sample size outputs with rapid scenario recalculation. Select Cytel EAST or nQuery when adaptive interim decision rules must stay testable across re-simulations that are linked to updated protocol artifacts.

  • Choose traceability-first modeling when assumption lineage must be auditable across stakeholders

    Select Berry Consultants FACTS when retained design inputs and side-by-side design assumption comparisons are required for simulation-driven iteration. Select nQuery when protocol simulation must tie interim rules and enrollment assumptions to operating characteristics with structured design inputs.

  • Choose governance-first enterprise configuration when protocol artifacts must stay synchronized across operations

    Select Oracle Clinical One when study provisioning flows must align protocol configuration with Oracle clinical workflows and audit logging. Select Veeva Vault Clinical when Vault-native review and change tracking must keep protocol-relevant artifacts synchronized with clinical operations handoffs.

  • Choose template-driven publishing when document lifecycle control outweighs adaptive modeling

    Select Sealed Envelope when the core requirement is governed eTMF document design and publishing with reusable form and metadata templates across protocol amendments. Reject it for protocol simulation and adaptive randomization calculations if those engines are required inside the same workflow.

  • Choose EDC workflow tooling when the design decision logic is handled elsewhere

    Select Castor EDC when protocol-driven visit schedules, CRF routing, and validation logic must be configured in one editable workflow definition. Select OpenClinica when audit-oriented workflows for form changes, queries, and approvals drive the operational requirement, even if adaptive execution is not native.

  • Validate the integration boundary for downstream eTMF and CDISC-aligned artifacts

    Treat end-to-end automation as a gap where modeling tools focus on simulation and where configuration tools focus on governed artifacts. IBM SPSS SamplePower supports modeling and scenario iteration but has limited integration with clinical operations systems, while Sealed Envelope supports governed publishing but does not cover adaptive simulation.

Who Trial Design Software fits best in clinical planning and operations

Different teams treat trial design software as either a modeling engine or a governed protocol configuration layer. The fit depends on whether the workflow needs simulation iteration from structured inputs or governance and audit tracking for protocol artifacts moving into operations.

  • Clinical statisticians running repeatable feasibility iterations

    IBM SPSS SamplePower fits when standardized assumptions must produce power and sample size outputs with quick scenario recalculation for feasibility drafts.

  • Adaptive design teams that require interim decision-rule consistency across re-simulations

    Cytel EAST supports structured adaptive decision logic linked to simulation iterations, and nQuery ties interim analysis and adaptive decision rules to measurable operating characteristics.

  • Protocol governance teams operating inside enterprise study systems

    Oracle Clinical One supports controlled provisioning and audit logging for configuration-to-CDISC-aligned downstream traceability, and Veeva Vault Clinical keeps Vault-native review and change tracking synchronized with study operations.

  • Teams building governed eTMF document design and publishing pipelines

    Sealed Envelope fits when controlled review steps and template reuse across protocol amendments drive document lifecycle workflows.

  • Trial operations teams focused on audit-tracked form changes and query handling

    OpenClinica fits when audit-oriented workflows for form changes, queries, and approvals are prioritized, while adaptive randomization logic is not a native execution focus.

Common procurement mistakes for Trial Design Software

Mistakes happen when procurement teams measure tool value only by modeling outputs or only by governance workflows. The category has split responsibilities, so choosing a tool that lacks the needed execution surface creates rework during authoring, simulation-to-artifact transfer, or study operations handoffs.

  • Buying a modeling tool expecting native orchestration of protocol workflows

    IBM SPSS SamplePower is oriented toward scenario recalculation and simulation planning, and it does not provide primary end-to-end automation with clinical operations systems. Veeva Vault Clinical keeps Vault workflows synchronized, but it does not provide protocol simulation and adaptive design engines natively.

  • Ignoring downstream authoring effort when outputs still require manual translation

    Berry Consultants FACTS retains design inputs for traceability, but outputs may still require downstream formatting for specific eTMF or sponsor templates. Cytel EAST keeps design-to-simulation traceability, but some protocol artifact authoring can require manual translation of outputs.

  • Selecting an eTMF or EDC configuration tool for adaptive design execution needs

    Sealed Envelope is built for configurable form and metadata templates tied to eTMF lifecycle publishing and it is not designed for protocol simulation or adaptive randomization calculations. Castor EDC and OpenClinica focus on EDC configuration and audit-oriented operational workflows, while adaptive design artifacts like interim analysis planning are not native design modules.

  • Underestimating governance setup work for protocol configuration-heavy environments

    Oracle Clinical One includes study provisioning flows and governance patterns with controlled authoring and review, which increases dependence on specialized configuration for complex adaptive randomization. Veeva Vault Clinical workflow configuration requires governance discipline to prevent inconsistent study setup.

How We Selected and Ranked These Tools

We evaluated IBM SPSS SamplePower, Berry Consultants FACTS, Cytel EAST, nQuery, Sealed Envelope, G*Power, Veeva Vault Clinical, Oracle Clinical One, Castor EDC, and OpenClinica against simulation traceability, scenario recalculation fit for planning iterations, and governed protocol artifact alignment across study lifecycles. Features took 40% weight, and ease and value each took 30% weight to reflect whether teams can produce repeatable design outputs without excessive setup time.

IBM SPSS SamplePower separated itself on input-driven power and sample size computation with scenario recalculation that supports rapid feasibility iterations, and it scored 9.3 For features with a 9.0 Overall ease rating. Tools that focused mainly on governed publishing templates, EDC audit workflows, or enterprise configuration scored lower for adaptive modeling coverage because interim rules and adaptive design execution were not native in those workflows.

Frequently Asked Questions About Trial Design Software

How does IBM SPSS SamplePower differ from nQuery in handling adaptive design decision rules?
IBM SPSS SamplePower centers on power and sample-size computation from standardized inputs, which keeps iteration focused on quantitative assumptions rather than adaptive decision-rule logic. nQuery from Statsols ties simulation and protocol decision rules to operating characteristics so interim analysis and adaptive workflows stay connected to measurable outcomes.
Which tool is better for assumption-to-output traceability when trial simulations drive design decisions?
Berry Consultants FACTS supports trial simulation modeling with documented assumptions that remain traceable from inputs to outputs. Cytel EAST also targets traceability, but it keeps interim decision rules consistent across re-simulations by maintaining a design-to-simulation mapping for protocol artifact updates.
How does Cytel EAST connect adaptive Bayesian elements to protocol-level artifacts?
Cytel EAST treats simulation as a first-class step and builds design configuration for adaptive components like Bayesian dose-finding and interim decision rules. It then converts those configured inputs into protocol-level artifacts so re-running simulations produces aligned changes to downstream content.
When does G*Power become a better fit than tools built around protocol simulation workflows?
G*Power fits study planning cycles that mainly require frequentist power and frequentist sample-size calculations for common parametric tests. When work requires protocol simulation under interim decision rules, nQuery from Statsols or Cytel EAST provides the decision-rule testing loop that G*Power does not model end to end.
What breaks if a clinical team tries to use Sealed Envelope for statistical interim analysis planning?
Sealed Envelope focuses on governed eTMF document design and publishing workflows using configurable templates and metadata. It does not provide statistical engines for interim analysis planning or adaptive decision-rule simulation, so design-time operating characteristics must be handled outside the eTMF workflow.
How does Oracle Clinical One handle study provisioning and lineage from configuration to downstream artifacts?
Oracle Clinical One emphasizes governance, lineage, and standards alignment through controlled provisioning and audit logging tied to study build tasks. Veeva Vault Clinical stays tightly aligned to Vault workflows and roles, but Oracle Clinical One is more explicit about traceability from study configuration to CDISC-aligned downstream representations.
How do integration and interoperability expectations differ between Sealed Envelope and OpenClinica?
Sealed Envelope integrates through automation hooks around review circulation and controlled publishing of structured trial documents tied to the study document lifecycle. OpenClinica centers on configurable study setup and EDC operations, then supports integration patterns for importing and exporting study data and for connecting systems used in reporting.
What data model and schema mapping differences show up between Castor EDC and Oracle Clinical One?
Castor EDC generates configurable EDC workflows from structured study definitions, including CRF routing, edit checks, and calendar logic, then supports CDISC-aligned exchange patterns for downstream analysis. Oracle Clinical One is designed around governed study configuration and controlled handoffs into CDISC-aligned representations, which emphasizes lineage and standards alignment in provisioning rather than EDC workflow generation.
How do admin controls and audit logging support security in OpenClinica versus Veeva Vault Clinical?
OpenClinica provides RBAC and uses audit tracking for query and data issue resolution workflows across study operations. Veeva Vault Clinical supports role-based Vault workflow governance and change tracking for protocol-relevant artifacts, which keeps protocol workflow status synchronized with Vault-based operations.
Which tool best supports getting started with repeatable design feasibility inputs that update quickly across scenarios?
IBM SPSS SamplePower supports input-driven power and sample-size computations where scenario recalculation stays fast for repeatable feasibility iteration. Berry Consultants FACTS also supports repeatable outputs, but it shifts the workflow emphasis toward simulation modeling and protocol feasibility checks rather than rapid parameter-only recalculation.

Tools reviewed

Primary sources checked during evaluation.

Referenced in the comparison table and product reviews above.

Keep exploring

FOR SOFTWARE VENDORS

Not on this list? Let’s fix that.

Our best-of pages are how many teams discover and compare tools in this space. If you think your product belongs in this lineup, we’d like to hear from you—we’ll walk you through fit and what an editorial entry looks like.

Apply for a Listing

WHAT THIS INCLUDES

  • Where buyers compare

    Readers come to these pages to shortlist software—your product shows up in that moment, not in a random sidebar.

  • Editorial write-up

    We describe your product in our own words and check the facts before anything goes live.

  • On-page brand presence

    You appear in the roundup the same way as other tools we cover: name, positioning, and a clear next step for readers who want to learn more.

  • Kept up to date

    We refresh lists on a regular rhythm so the category page stays useful as products and pricing change.